Episode 3 of the Therapeutic Science and Strategy Podcast Series recorded by Lumanity
In this third episode, Joel Sandler sits down with Mitch Petrick, Board of Trustees Member, Cancer Research Institute, to explore:
- Background on Mitch and his rare form of thyroid cancer
- His journey from initial diagnosis (which he made!) through to referral and treatment
- Some thoughts about the drug development process and system from the perspective of someone in need of new solutions
- Lessons for drug manufacturers and healthcare providers
